Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis

Federico Prefumo; Pier Luigi Venturini; Ezio Fulcheri

doi:10.1097/00004347-200301000-00016

Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis

Federico Prefumo, Pier Luigi Venturini, Ezio Fulcheri

Research output: Contribution to journal › Article › peer-review

Abstract

We assessed the immunohistochemical expression of p53 and c-erbB-2 oncoproteins in 13 ovarian endometrioid adenocarcinomas arising from endometriosis (group 1) and compared the findings with 15 otherwise similar cases without associated endometriosis (group 2). Tumors in group 1 showed a higher expression of both p53 and c-erbB-2 (p=0.015 and p=0.048, respectively). The expression of the two proteins was also significantly associated in group 1 (p=0.013) but not in group 2 (p = 0.63) tumors. The different pattern of expression of p53 and c-erbB-2 in the two groups suggests that different molecular pathways may be involved in their pathogenesis.

Original language	English
Pages (from-to)	83-88
Number of pages	6
Journal	International Journal of Gynecological Pathology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1097/00004347-200301000-00016
Publication status	Published - Jan 2003

Keywords

c-erbB-2
Endometriosis
Ovarian endometrioid carcinoma
P53

ASJC Scopus subject areas

Pathology and Forensic Medicine
Obstetrics and Gynaecology

Access to Document

10.1097/00004347-200301000-00016

Fingerprint Dive into the research topics of 'Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis'. Together they form a unique fingerprint.

Cite this

@article{b69125199c0e4c6ab7a95d08bdab89fc,

title = "Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis",

abstract = "We assessed the immunohistochemical expression of p53 and c-erbB-2 oncoproteins in 13 ovarian endometrioid adenocarcinomas arising from endometriosis (group 1) and compared the findings with 15 otherwise similar cases without associated endometriosis (group 2). Tumors in group 1 showed a higher expression of both p53 and c-erbB-2 (p=0.015 and p=0.048, respectively). The expression of the two proteins was also significantly associated in group 1 (p=0.013) but not in group 2 (p = 0.63) tumors. The different pattern of expression of p53 and c-erbB-2 in the two groups suggests that different molecular pathways may be involved in their pathogenesis.",

keywords = "c-erbB-2, Endometriosis, Ovarian endometrioid carcinoma, P53",

author = "Federico Prefumo and Venturini, {Pier Luigi} and Ezio Fulcheri",

year = "2003",

month = jan,

doi = "10.1097/00004347-200301000-00016",

language = "English",

volume = "22",

pages = "83--88",

journal = "International Journal of Gynecological Pathology",

issn = "0277-1691",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis

AU - Prefumo, Federico

AU - Venturini, Pier Luigi

AU - Fulcheri, Ezio

PY - 2003/1

Y1 - 2003/1

N2 - We assessed the immunohistochemical expression of p53 and c-erbB-2 oncoproteins in 13 ovarian endometrioid adenocarcinomas arising from endometriosis (group 1) and compared the findings with 15 otherwise similar cases without associated endometriosis (group 2). Tumors in group 1 showed a higher expression of both p53 and c-erbB-2 (p=0.015 and p=0.048, respectively). The expression of the two proteins was also significantly associated in group 1 (p=0.013) but not in group 2 (p = 0.63) tumors. The different pattern of expression of p53 and c-erbB-2 in the two groups suggests that different molecular pathways may be involved in their pathogenesis.

AB - We assessed the immunohistochemical expression of p53 and c-erbB-2 oncoproteins in 13 ovarian endometrioid adenocarcinomas arising from endometriosis (group 1) and compared the findings with 15 otherwise similar cases without associated endometriosis (group 2). Tumors in group 1 showed a higher expression of both p53 and c-erbB-2 (p=0.015 and p=0.048, respectively). The expression of the two proteins was also significantly associated in group 1 (p=0.013) but not in group 2 (p = 0.63) tumors. The different pattern of expression of p53 and c-erbB-2 in the two groups suggests that different molecular pathways may be involved in their pathogenesis.

KW - c-erbB-2

KW - Endometriosis

KW - Ovarian endometrioid carcinoma

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=0037216292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037216292&partnerID=8YFLogxK

U2 - 10.1097/00004347-200301000-00016

DO - 10.1097/00004347-200301000-00016

M3 - Article

C2 - 12496703

AN - SCOPUS:0037216292

VL - 22

SP - 83

EP - 88

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 1

ER -

Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this